Menu

Experience

Madison Jones

    • Scholar Rock – $205 Million Registered Direct Offering 


    • MaxCyte – $202 Million IPO 


    • Werewolf Therapeutics – $120 Million IPO 


    • Olink Holding – $406 Million IPO 


    • Instil Bio – $368 Million IPO 


    • Landos Biopharma – $100 Million IPO 


    • Taysha Gene Therapies – $181 Million IPO 


    • iTeos Therapeutics – $201 Million IPO 


    • PolyPid – $69 Million IPO 


    • Calliditas Therapeutics - $90 Million IPO 


    • argenx – $557 Million Follow-On Offering 


    • SpringWorks Therapeutics – $186 Million IPO  


    • NextCure – $86 Million IPO 


    • PhaseBio Pharmaceuticals – $46 Million IPO 


    • Endava – $146 Million IPO 


    • Recro Pharma – $15 Million Follow-On  


    • AveXis – $95 Million IPO 


    • Tenable – $288 Million IPO